Amanote Research

Amanote Research

    RegisterSign In

The Efficacy of Betulinic Acid in Triple-Negative Breast Cancer

SAGE Open Medicine - United Kingdom
doi 10.1177/2050312114551974
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

January 1, 2014

Authors
Daniel WeberMixia ZhangPengwei ZhuangYanjun ZhangJanelle WheatGeoffrey CurrieZaynab Al-Eisawi
Publisher

SAGE Publications


Related search

The Efficacy of Andrographolide and Its Combination With Betulinic Acid in the Treatment of Triple Negative Breast Cancer

Cancer therapy & Oncology International Journal
2017English

Triple-Negative Breast Cancer

2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy